Abraham Scaria

Abraham Scaria

Company: Beacon Therapeutics

Job title: Chief Scientific Officer

Seminars:

2:00PM Fireside Chat: Optimizing Gene Therapy Delivery through Different Administration Routes 2:00 pm

• Compare and contrast delivery methods like intraocular, sub-retinal, and emerging techniques • Discuss challenges unique to each route, including surgical complexity, patient tolerance, and immune considerations • Brainstorm ideas for minimizing invasiveness while maintaining delivery accuracyRead more

day: Conference Day 2

2:30PM Comparing Sub-Retinal vs. Intra-Vitreal Delivery Methods to Maximize Safety & Precision in Gene Therapy 2:30 pm

• Analyze the pros and cons of sub-retinal delivery (high precision but invasive) and intravitreal injections (less invasive but higher inflammation risk) • Share real-world examples or studies highlighting outcomes with each approach • Explore technical advancements and innovations aimed at improving these delivery routesRead more

day: Conference Day 2

9:00AM Keynote Panel: Gene Therapy Immunogenicity: Challenges, Innovations & the Road to Safe & Effective Therapies 9:00 am

• Overview of recent advancements in gene therapy, focusing on immunogenicity as a critical bottleneck in development and clinical success • Novel tools for immunogenicity assessment, including predictive modeling, biomarkers, and innovative vector designs to minimize immune responses • Collaborative strategies to overcome immunogenicity challenges, streamline regulatory approvals, and deliver safe and effective therapies to…Read more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.